Apimeds Pharmaceuticals US, Inc

APUS

APUSApimeds Pharmaceuticals US, Inc US flag

New York Stock Exchange American

1.35

USD

+0.03

- -

1.70MMarket Cap

Income Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Sales/Revenue/Turnover	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	- -	- -	- -	- -
- Cost of Revenue	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -
- Operating Expenses	1	1	1	1	12
+ Selling, General & Admin	1	- -	1	1	10
+ Research & Development	- -	- -	- -	- -	2
+ Other Operating Expense	- -	- -	- -	- -	- -
Operating Income (Loss)	-1	-1	-1	-1	-12
- Non-Operating (Income) Loss	- -	- -	- -	- -	-6
+ Interest Expense, Net	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	-6
Pretax Income	-1	-1	-1	-1	-6
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-1	-1	-1	-1	-6
- Net Extraordinary Losses (Gains)	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-1	-1	-1	-1	-6
- Minority Interest	- -	- -	- -	- -	- -
Net Income, GAAP	-1	-1	-1	-1	-6
- Preferred Dividends	- -	- -	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-1	-1	-1	-1	-6
EBIT	-1	-1	-1	-1	-12
EBITDA	-1	-1	-1	-1	-12
EBITDA Margin (%)	- -	- -	- -	- -	- -
EBITA	-1	-1	-1	-1	-12
Gross Margin (%)	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	12	12	12	12	- -
Basic EPS, GAAP	-0.09	-0.06	-0.07	-0.12	- -
Basic EPS from Cont Ops	-0.09	-0.06	-0.07	-0.12	- -
Diluted Weighted Avg Shares	12	12	12	12	- -
Diluted EPS, GAAP	-0.09	-0.06	-0.07	-0.12	- -
Diluted EPS from Cont Ops	-0.09	-0.06	-0.07	-0.12	- -

Balance Sheet (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Current Assets	- -	- -	- -	- -	14
+ Cash, Cash Equivalents & STI	- -	- -	- -	- -	4
+ Cash & Cash Equivalents	- -	- -	- -	- -	2
+ ST Investments	- -	- -	- -	- -	2
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	- -	- -	10
+ Misc ST Assets	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	150
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -
+ Property, Plant & Equip	- -	- -	- -	- -	- -
- Accumulated Depreciation	- -	- -	- -	- -	- -
+ LT Investments & Receivables	- -	- -	- -	- -	150
+ LT Investments	- -	- -	- -	- -	150
+ LT Receivables	- -	- -	- -	- -	- -
+ Other LT Assets	- -	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -
Total Assets	- -	- -	- -	- -	164
+ Payables & Accruals	- -	- -	- -	1	1
+ Accounts Payable	- -	- -	- -	1	1
+ Accrued Taxes	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	- -	1
+ ST Debt	- -	- -	- -	- -	8
+ ST Borrowings	- -	- -	- -	- -	8
+ ST Finance Leases	- -	- -	- -	- -	- -
+ Other ST Liabilities	- -	- -	- -	- -	2
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	- -	2
Total Current Liabilities	- -	- -	- -	1	11
+ LT Debt	- -	- -	- -	- -	- -
+ LT Borrowings	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	- -
+ Other LT Liabilities	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -
+ Misc LT Liabilities	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	- -	- -	- -	- -	- -
Total Liabilities	- -	1	- -	1	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -
+ Share Capital & APIC	1	2	3	3	164
+ Common Stock	- -	- -	- -	- -	- -
+ Additional Paid in Capital	1	1	3	3	164
- Treasury Stock	- -	- -	- -	- -	- -
+ Retained Earnings	-2	-2	-3	-4	-10
+ Other Equity	- -	- -	- -	- -	- -
Equity Before Minority Interest	- -	-1	- -	-1	153
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -
Total Equity	- -	-1	- -	-1	153
Total Liabilities & Equity	- -	- -	- -	- -	164
Shares Outstanding	12	12	12	12	13
Number of Employees	- -	- -	- -	- -	- -
Capital Leases - Total	- -	- -	- -	- -	- -
Net Debt	- -	1	- -	1	6
Net Debt to Equity	-95.84	-91.62	-450.56	-43.69	3.88
Tangible Common Equity Ratio	-138.52	-11,563.86	7.55	-10,401.48	93.35
Current Ratio	16.16	0.02	3.42	0.01	1.31
Cash Conversion Cycle	- -	- -	- -	- -	- -

Cash Flow Statement (USD)

API Chat

	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
+ Net Income	-1	-1	-1	-1	-6
+ Depreciation & Amortization	- -	- -	- -	- -	- -
+ Non-Cash Items	- -	- -	- -	- -	- -
+ Stock-Based Compensation	- -	- -	- -	- -	3
+ Deferred Income Taxes	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	- -	-3
+ Chg in Non-Cash Work Cap	- -	- -	- -	1	-3
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	-2
+ Inc (Dec) in Accts Payable	- -	- -	- -	1	- -
+ Inc (Dec) in Other	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Operating Activities	-1	- -	-1	-1	-9
+ Change in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	1	- -	12
+ Increase in Capital Stock	- -	- -	1	- -	12
+ Decrease in Capital Stock	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	-2
+ Dec in LT Investment	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	-2
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	-8
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	-10
+ Dividends Paid	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	10
+ Cash From Debt	- -	- -	- -	- -	10
+ Repayments of Debt	- -	- -	- -	- -	- -
+ Other Financing Activities	- -	- -	- -	- -	-1
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	- -	1	- -	21
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -
Net Changes in Cash	- -	- -	- -	- -	2
EBITDA	-1	-1	-1	-1	-12
EBITDA Margin (%)	- -	- -	- -	- -	- -
Free Cash Flow	-1	- -	-1	-1	-9
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -
Free Cash Flow to Firm	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	- -	-1	- -	1
Free Cash Flow per Basic Share	-0.07	-0.04	-0.05	-0.06	- -
Price/Free Cash Flow	- -	- -	- -	- -	- -
Cash Flow to Net Income	0.8	0.67	0.81	0.53	1.49
Capital Expenditures	- -	- -	- -	- -	- -